AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants support researchers studying druggable targets and biomarkers to advance new kidney cancer treatments, diagnosis, monitoring, and prognosis.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.
The KCA Awards Program supports kidney cancer investigators with research on disease biology, treatment vulnerabilities and lifestyle factors to improve care and guide future work.
Young Investigator Research Grant supports early-career investigators conducting patient-oriented clinical research to improve kidney disease detection, prevention, treatment, transplantation, and patients’ lives.
The Chromophobe RCC Research Grant Award supports researchers studying a rare kidney cancer, funding innovative work shaped by patient priorities to generate preliminary data and pursue clinical impact.
The PKD Foundation Research Grants fund innovative research into the biology, mechanisms, and treatment of polycystic kidney disease across basic to clinical science.